Drugs / AIDSVAX B/E
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02207920 | Jul 2014 → Dec 2015 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AIDSVAX B/E | “the DNA-HIV-PT123 vaccine and the AIDSVAX® B/E vaccine” NCT02207920 ↗ |
| Modality | Vaccine | “AIDSVAX B/E Vaccine” NCT02207920 ↗ |